CAMBRIDGE, Mass. and CHARLOTTE, N.C. – Digital therapeutics company Voluntis is teaming with glucose management company Monarch Medical Technologies to develop strategies aimed at improving the coordination of glycemic management for patients with insulin dosing recommendations in both the inpatient and outpatient setting. The objective in combining the power of these two systems is to take patients from successful insulin dosing in the hospital, using Monarch’s EndoTool Glucose Management System, to continued effective insulin treatment at home, using Voluntis’ Insulia automated insulin dosing and coaching for daily follow-up. “With both EndoTool and Insulia, providers can be confident that their patients continue to receive personalized dosing recommendations at home, to achieve and maintain target glucose levels,” said Pierre Leurent, CEO and cofounder of Voluntis, in a statement.
You are here: / / Voluntis, Monarch Medical partner to offer insulin dosing from hospital to home